HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E Chu Selected Research

Therapeutics

3/2014Epidemiology and natural history of central venous access device use and infusion pump function in the NO16966 trial.
10/2012Accelerated cellular senescence in solid tumor therapy.
9/2010Expression of coxsackie and adenovirus receptor distinguishes transitional cancer states in therapy-induced cellular senescence.
11/2001An adverse interaction between warfarin and capecitabine: a case report and review of the literature.
9/2000Thyroid cancer: patients' experiences of receiving iodine-131 therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


E Chu Research Topics

Disease

9Neoplasms (Cancer)
10/2016 - 09/2000
4Colorectal Neoplasms (Colorectal Cancer)
03/2014 - 08/2001
3Colonic Neoplasms (Colon Cancer)
01/2001 - 03/2000
1Hyperglycemia
10/2016
1Lymphoma (Lymphomas)
10/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2016
1Hemorrhage
11/2001
1Disease Progression
09/2001
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
09/2001
1Neoplasm Metastasis (Metastasis)
09/2001
1Lung Neoplasms (Lung Cancer)
04/2001
1Thyroid Diseases (Thyroid Disease)
09/2000
1Thyroid Neoplasms (Thyroid Cancer)
09/2000
1Genetic Translocation (Chromosomal Translocation)
09/2000
1Wilms Tumor (Wilm's Tumor)
09/2000
1Ewing Sarcoma (Sarcoma, Ewing)
09/2000
1Ocular Hypotension
06/2000

Drug/Important Bio-Agent (IBA)

2Thymidylate SynthaseIBA
11/2001 - 01/2001
2Biomarkers (Surrogate Marker)IBA
11/2001 - 09/2001
2DNA (Deoxyribonucleic Acid)IBA
09/2001 - 09/2000
2Proteins (Proteins, Gene)FDA Link
04/2001 - 11/2000
2LuciferasesIBA
11/2000 - 03/2000
1copanlisibIBA
10/2016
1Class I Phosphatidylinositol 3-KinasesIBA
10/2016
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2016
1adenovirus receptorIBA
09/2010
1Capecitabine (Xeloda)FDA Link
11/2001
1Warfarin (Coumadin)FDA LinkGeneric
11/2001
1ProdrugsIBA
11/2001
1Fluorouracil (Carac)FDA LinkGeneric
11/2001
1Antineoplastic Agents (Antineoplastics)IBA
11/2001
1Epstein-Barr virus encoded RNA 1IBA
09/2001
1Transcription Factors (Transcription Factor)IBA
04/2001
1TubulinIBA
01/2001
1Actins (F Actin)IBA
01/2001
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2001
1Iodine-131IBA
09/2000
1Complementary DNA (cDNA)IBA
09/2000
1SpiperoneIBA
06/2000
1(5,6-dimethoxyindan-2-yl)dipropylamineIBA
06/2000
17-hydroxy-2-N,N-dipropylaminotetralinIBA
06/2000
1RacloprideIBA
06/2000

Therapy/Procedure

5Therapeutics
03/2014 - 09/2000
4Drug Therapy (Chemotherapy)
09/2010 - 01/2001
1Infusion Pumps (Infusion Pump)
03/2014
1Palliative Care (Palliative Therapy)
12/2013
1Neoadjuvant Therapy
09/2010
1Combination Drug Therapy (Combination Chemotherapy)
09/2001
1Sympathectomy (Sympathectomies)
06/2000